A case of malignant mastocytosis with circulating mast cell precursors: Biologic and phenotypic characterization of the malignant clone

Leukemia

Volumn 10, Issue 1, 1996, Pages 159-166

  Baghestanian, M ^a   Bankl, H C ^a   Sillaber, C ^a   Beil, W J ^a   Radaszkiewicz, Th ^a   Fureder W ^a   Preiser, J ^b   Vesely, M ^c   Schernthaner, G ^b   Lechner, K ^a   Valent, P ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b KRANKENANSTALT RUDOLFSTIFTUNG   (Austria)

^c GENERAL HOSPITAL LINZ   (Austria)

Author keywords

C kit; C5aR; Mast cell leukemia; SCF; Tryptase

Indexed keywords

ALPHA2B INTERFERON; ANTIBIOTIC AGENT; CD33 ANTIGEN; CD9 ANTIGEN; CHYMASE; GROWTH FACTOR RECEPTOR; HERMES ANTIGEN; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR AGONIST; INTERLEUKIN 3; OMEPRAZOLE; RECOMBINANT STEM CELL FACTOR; TOLONIUM CHLORIDE; TRYPTASE;

ADULT; ARTICLE; CASE REPORT; CELL CLONE; ELECTRON MICROSCOPY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MALE; MAST CELL; MASTOCYTOSIS; MONONUCLEAR CELL; PRIORITY JOURNAL; STEM CELL;

EID: 9044235583     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Metcalfe DD. Classification and diagnosis of mastocytosis: current status. J Invest Dermatol 1991; 96: 2S-4S.
2. Horan RF, Austen KF. Systemic mastocytosis: retrospective review of a decade's clinical experience at the Brigham and Women's Hospital. J Invest Dermatol 1991; 96: 5S-14S.
3. Travis WD et al. Mast cell leukemia: report of a case and review of the literature. Mayo Clin Proc 1986; 61: 957-966.
4. Horny HP, Ruck M, Wehrmann M, Kaiserling E. Blood findings in generalized mastocytosis: evidence of frequent simultaneous occurrence of myelo-proliferative disorders. Br J Haematol 1990; 76. 186-193.
5. Webb TA, Li CY, Yam LT. Systemic mast cell disease: a clinical and hematopathologic study of 26 cases. Cancer 1982; 49: 927-938.
6. Travis WD et al. Significance of systemic mast cell disease with associated hematologic disorders: Cancer 1988; 62: 965-972.
7. Parwaresch MR, Horny HP, Lennert K. Tissue mast cells in health and disease: Path Res Pract 1985; 179: 439-461
8. Kluin-Nelemans HC et al. Response to interferon alpha-2b in a patient with systemic mastocytosis. New Engl J Med 1992; 326: 619-623
9. Galli SJ. Biology of disease: new insights into 'the riddle of the mast cells': microenvironmental regulation of mast cell development and phenotypic heterogeneity. Lab Invest 1990; 62: 5-33.
10. Kitamura Y et al. Spleen colony forming cell as common precursor for tissue mast cells and granulocytes: Nature 1981; 291: 159-160.
11. + pluri-potent progenitor cells J Immunol 1992; 148: 772-777.
12. - colony forming cell. J Immunol 1993; 151: 4221-4227.
13. Födinger M et al Origin of human mast cells: development from transplanted hemopoietic stem cells after allogeneic bone marrow transplantation Bood 1994; 84: 2954-2959.
14. Dvorak AM. Basophil and mast cell degranulation and recovery. In: Harris JR (ed). Blood Cell Biochemistry. Plenum Press: New York; 1991, pp 1-370.
15. Galli SJ. New concepts about the mast cell. New Eng J Med 1992; 328. 257-265.
16. Denburg JA. Mast cell lineages in vivo and in vitro. Blood 1992; 79: 846-860.
17. Schwartz LB, Huff TF. Mast cells. In: Crystal RC, et al (eds): The Lung. NY Raven Press: New York; 1991, pp 601-616.
18. Valent P, Bettelheim P. Cell surface structures on human basophils and mast cells: biochemical and functional characterization. Adv Immunol 1992; 52: 333-421.
19. Saito H et al. Selective differentiation and proliferation of hematopoietic cells induced by recombinant human interleukins. Proc Natl Acad Sci USA 1988; 85: 2288-2292.
20. Valent P et al: Interleukin-3 is a differentiation factor for human basophils. Blood 1989; 73: 1763-1769.
21. Valent P et al Failure to detect interleukin-3 binding sites on human mast cells. J Immunol 1990; 145: 3432-3438.
22. Fifth International Workshop and Conference on Human Leukocyte Differentiation Antigens. Schlossman et al (eds). Oxford University Press: Oxford, 1995.
23. Agis H et al. Comparative immunophenotypic analysis of human mast cells, blood basophils and monocytes: dissection of three distinct lineages. Immunology (in press).
24. Bischoff SC, Dahinden CA. c-kit ligand: a unique potentiator of mediator release from human lung mast cells. J Exp Med 1992; 175: 237-244.
25. Columbo M et al. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils: J Immunol 1992; 149: 599-608.
26. Sperr WR et al. Specific activation of human mast cells by the ligand for c-kit. comparison between lung, uterus and heart mast cells. Int Arch Allergy Appl Immunol 1993; 102: 170-175.
27. Valent P et al. Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor (SCF)/kit ligand (KL) in long term culture Blood 1992; 80: 2237-2245.
28. Mitsui H et al. Development of human mast cells from umbilical cord blood cells by recombinant human and murine stem cell factor, c-kit ligand. Proc Natl Acad Sci USA 1993; 90: 735-740
29. Irani AM et al. Recombinant human stem cell factor stimulates differentiation of human mast cells from dispersed fetal liver cells. Blood 1992; 80: 3009-3021.
30. Kitamura Y, Nakayama H, Fujita J. Mechanisms of mast cell deficiency in mutant mice of W/Wv and Sl/Sld genotype. In: Galli SJ, Austen KF (eds). Mast Cell and Basophil Differentiation and Function in Health and Disease. Raven Press: New York, 1989, pp 12-15.
31. Furitsu T et al. Identification of mutation in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product. J Clin Invest 1993; 92: 1736-1744.
32. Irani AA et al. Two human mast cell subsets with distinct neutral protease compositions. Proc Natl Acad Sci USA 1986; 83: 4464-4468.
33. Irani AM et al. Detection of MC-T and MC-TC types of human mast cells by immunohistochemistry using new monoclonal anti-tryptase and anti-chymase antibodies. J Histochem Cytochem 1989; 37: 1509-1515.
34. Weidner N, Austen KF. Heterogeneity of mast cells at multiple sites: Path Res Pract 1993; 189: 156-162.
35. Füreder W et al. Differential expression of complement receptors on human basophils and mast cells: evidence for mast cell heterogeneity and CD88/C5aR expression on skin mast cells. J Immunol 1995; 155; 3152-3160.
36. Lawrence ID et al. Purification and characterization of human skin mast cells. J Immunol 1987; 139: 3062-3069.
37. Benyon RC, Lowman MA, Church MK. Human skin mast cells. Their dispersion, purification, and secretory characterization. J Immunol 1987; 138: 861-867.
38. Dvorak AM. Human mast cells. Ultrastructural observations of in situ, ex vivo, and in vitro sites, sources and systems. In: Kaliner AM, Metcalfe DD (eds). The Mast Cell in Health and Diseases, Marcel Dekker: New York, 1992, pp 1-87.
39. Mayrhofer G, Gadd SJ, Spargo LDJ, Ashman LK. Specificity of a mouse monoclonal antibody raised against acute myeloid leukemia cells for mast cells in human mucosal and connective tissues. Immunol Cell Biol 1987; 65: 241-242.
40. Bankl HC et al. Increase and redistribution of mast cells in auricular thrombosis: possible role of kit ligand. Circulation 1995; 91: 275-283.
41. Hsu SM, Raine L, Fanger H. Use of avidine-biotine-peroxidase complex (ABC) in immunoperoxidase techniques: J Histochem Cytochem 1981; 29: 1509-1515.
42. Beil WJ et al. Ultrastructural immunogold localization of subcellular sites of TNF-α in colonic Crohn's disease. J Leukocyte Biol 1995; 58: 284-298.
43. Dvorak AM, Monahan RA, Dickersin CR. Diagnostic electron microscopy. I. Hematology: differential diagnosis of acute lymphoblastic and acute myeloblastic leukemia. Use of ultrastructural peroxidase cytochemistry and routine electron microscopic technology. Pathol Annu 1981; 16: 101-137.
44. Dvorak AM. Monograph - Procedural guide to specimen handling for the ultrastructural pathology service laboratory J Electron Microsc Tec 1987; 6: 255-259.
45. Dvorak AM, Furitsu T, Ishizaka T. Ultrastructural morphology of human mast cell progenitors in sequential cocultures of cord blood cells and fibroblasts. Int Arch Allergy Immunol 1993; 100. 219-229.
46. Valent P et at. Mast cell typing: demonstration of a distinct hemopoietic cell type and evidence for immunophenotypic relationship to mononuclear phagocytes. Blood 1989; 73: 1778-1885.
47. Valent P et al. Kit ligand/mast cell growth factor-independent differentiation of mast cells in myelodysplasia and chronic myeloid leukemia blast crisis. Blood 1994; 84: 4322-4332.